The phosphatase and tensin homolog (PTEN) tumour suppressor gene negatively regulates the PI3K/AKT pathway and PTEN is one of the most common tumour suppressor genes whose appropriate function is compromised in prostate cancer (~70% of cases) [32,33,34], which leads to abnormal proliferation and cell death. This evidence concerns the gene AKT1 and prostate carcinoma.